Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone acetonide intravitreal injection for exudative maculopathy
2006-001727-19Phase 3Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Dec 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of triamcinolone acetonide in Exudative Maculopathy and macular edema, sponsored by Sant'Orsola-Malpighi University Hospital. Started Dec 2006; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
Exudative Maculopathymacular edema
Beyond the preview
Go deeper on 2006-001727-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001727-19.